WHITEHOUSE, N.J. (PRWEB) MARCH 25, 2019
Abcam, a global innovator in life science reagents and tools, and Visikol, a contract research organisation focused on advancing drug discovery, have announced a collaboration to develop new reagents and kits for improved tissue clearing and 3D imaging.
Tissue clearing methods, which are essential to get a better view of complex structures such as the brain and nervous system, have advanced the understanding of neuroscience. These methods are also being rapidly adopted into the drug discovery and safety toxicology fields, where it’s vitally important to characterise 3D cell culture models in their entirety.
Dr. Tom Villani, Chief Scientific Officer, Visikol, commented: “Despite being an established technique, challenges such as antibody optimisation and labelling remain as tissue clearing requires the combination of several highly complex disciplines. This collaboration addresses the industry need for improved tools to undertake rapid tissue clearing and 3D imaging that generates high-quality data.”
Michael Chipchase, Senior Product Manager, Kits and Assays, Abcam, commented: “Collaboration with industry partners is part of Abcam’s strategy to provide scientists with the tools they need. By combining our expertise in antibody development and validation with Visikol’s expertise in tissue clearing, we can advance understanding of important biological processes to support the future development of critical diagnostics and therapeutics.”
Find out more at: http://www.abcam.com/tissueclearing
Notes to Editors
About Abcam
As a global life sciences company, Abcam identifies, develops, and distributes high-quality biological reagents and tools that are crucial to research, drug discovery and diagnostics. Working across the industry, the Company supports life scientists to achieve their mission, faster.
Abcam partners with life science organisations to co-create novel binders for use in drug discovery, in vitro diagnostics and therapeutics, driven by the Company’s proprietary discovery platforms and world-leading, antibody expertise.
By constantly innovating its binders and assays, Abcam is helping advance the global understanding of biology and causes of disease, which enables new treatments and improved health. The Company’s pioneering data-sharing approach gives scientists increased confidence in their results by providing validation, user comments and peer-reviewed citations for its 110,000 products.
With ten sites globally, many of Abcam’s 1,100 strong team are located in the world’s leading life science research hubs, complementing a global network of services and support.
To discover more, please visit http://www.abcam.com and http://www.abcamplc.com.
Download Tissue Clearing Ebook
If you are interested in learning more about tissue clearing, download our free ebook below which details how best to implement tissue clearing into your research workflow and which tissue clearing approach is best for your specific research question.
